NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-AI-22-006 from the NIH Guide for Grants and Contracts
Notice NOT-AI-22-005 from the NIH Guide for Grants and Contracts
Notice NOT-AI-21-082 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-065 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for support of national or regional resources that will provide access to state-of-the-art facilities, equipment, technologies, research tools, software, and/or service to a substantial user base at institutions across multiple states (regional) or the country (national). These resources should already be established, although new resources formed through consolidation of multiple local or regional facilities are also eligible. They should be poised to achieve or already have achieved significant economies of scale and should be able to significantly increase access to the supported technologies or services for researchers across one or more regions or the country. Major new research and development efforts should not be included. For this FOA, a resource is defined as an activity that provides research capabilities and expertise to a large number of investigators and is available to any qualified investigator as a service. The intent is to provide access to investigators without regard to the particular biomedical focus of their research, but not to duplicate or replace resources supported by other NIH Institutes and Centers (ICs) or host institutions. Only those resources whose technical capabilities fall within the program areas supported by NIGMS will be supported. It is expected that the resource will be maintained or upgraded to current best practices, make its capability and availability known to the biomedical research community through outreach activities, and provide user training and support. Stand-alone data resources and databases are not eligible for funding through this FOA. This FOA is limited to applications requesting support for resources that have been developed through previous NIGMS funding.
Notice NOT-HD-21-054 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-032 from the NIH Guide for Grants and Contracts. The overall goal of the Fostering Research With Additional Resources and Development (FORWARD) Urology Centers program is to foster and expand the benign urologic research community. FORWARD Urology Centers will support a Research Project designed and conducted by a collaborative, multidisciplinary team comprising junior investigators and/or researchers new to the field of benign urologic research. It is expected that the Research Project Team will generate data to support one or more follow-on independent grant applications (e.g., R01s). The Center PD(s)/PI(s) will lead an Administrative (Project Support) Core to provide guidance to the Research Team to help ensure the research aims are met and to aid them in their successful integration into the broader benign urologic research field. To facilitate these goals, the Center will leverage intra- and extra-institutional resources, collaborations and facilities and engage as a member of NIDDKs CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology) Program.
Funding Opportunity RFA-DK-21-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications for National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD). The Centers will provide complex metabolic, physiologic and behavioral phenotyping and consulting services to characterize living mouse models on a fair fee-for-service basis. Tests that do not require living animals will not be supported by this initiative. MPMODs may also provide special mouse models for study at the Center or for distribution, such as mice that have undergone bariatric surgery or implanted catheters. Services are provided with equal priority to investigators inside and outside the home institution, at similar cost, to study the heterogeneity, pathogenesis, and metabolic and physiologic consequences of diabetes and obesity. The MPMOD Centers will work together as a consortium, supported by a Coordinating Unit, to improve access to high quality consultation and phenotyping for metabolic disease research conducted in mice; establish outreach/advertising to potential clients; find ways to enable underrepresented PIs and those from small research institutions to produce outstanding results and better compete for funding; and be synergistic and cost-effective, includingdeveloping common test protocols and eliminating overlap where appropriate.
Funding Opportunity RFA-DK-21-035 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a Coordinating Unit (CU) to support the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD). MPMOD Centers, solicited via RFA DK-21-027,will ?provide complex metabolic, physiologic and behavioral phenotyping and consulting services to characterize living mouse models on a fair fee-for-service basis. Services are provided with equal priority to investigators inside and outside the home institution, at similar cost, to study the heterogeneity, pathogenesis, and metabolic and physiologic consequences of diabetes and obesity. The MPMOD Centers will work together as a consortium, supported by the Coordinating Unit, to improve access to high quality consultation and phenotyping for metabolic disease research conducted in mice. An important goal of this consortium will be to enable underrepresented PIs and those from small research institutions that traditionally have not received significant research funding and/or have historically served under-represented populations to produce outstanding results and better compete for funding.
Funding Opportunity PAR-22-031 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-147 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents.
Notice NOT-TR-22-010 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-084 from the NIH Guide for Grants and Contracts
Notice NOT-DC-22-006 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-032 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-146 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents.
Notice NOT-ES-22-004 from the NIH Guide for Grants and Contracts
Notice NOT-RM-22-005 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-23-010 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is to provide junior faculty pediatricians with state of the art training in an academic research setting to stimulate pediatric research over a variety of disciplines. The program provides supervised research career development opportunities to assist junior faculty in their transition to productive pediatrician scientists. The goal of the Child Health Research Career Development Award (CHRCDA) Program is to promote the performance of research and transfer of findings that will benefit the health of children. This will be accomplished by supporting research career development of new faculty-level pediatricians, to be known as CHRCDA Scholars. These K12 Program grant awards will generate well-qualified pediatrician scientists who will help meet the need for highly skilled physician investigators who can take advantage of new technologies and respond to the increasing demands of pediatric research.
Notice NOT-CA-22-019 from the NIH Guide for Grants and Contracts
Notice NOT-AR-21-028 from the NIH Guide for Grants and Contracts
Notice NOT-AT-22-003 from the NIH Guide for Grants and Contracts
Notice NOT-HL-21-025 from the NIH Guide for Grants and Contracts